+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts?



Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts?



Journal of Heart and Lung Transplantation 11(3 Pt 2): S14-S20



In conclusion, a great deal of indirect and inferential data point to herpesviruses as having a role in atherogenesis. It has been shown that the herpesviruses are able to remain within vascular tissue in a latent state, allowing for reactivation to occur with subsequent sequelae of an active infection. Herpesviruses affect the cellular metabolic activity of cells, induce the accumulation of lipids, and inhibit the production of matrix proteins. They have the ability to inhibit endothelial cell binding to the basement membrane. It is also known that the herpesviruses, particularly CMV, can initiate a variety of immunologic responses that may contribute to endothelial damage, precipitating atherogenesis. We are only beginning to understand how CMV may participate in ACAD. Greater attention must be focused on the exact cause-and-effect relationship between CMV infection and ACAD. Even the presence of CMV genomes in arterial walls of allografts must be viewed conservatively in the knowledge of CMV ubiquity and other probable contributions to ACAD. If CMV is involved in the development of ACAD, as an active or latent infection, directly or indirectly, it probably involves numerous coexistent mechanisms (Figure 5).

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030784519

Download citation: RISBibTeXText

PMID: 1320406


Related references

Molecular evaluation of a direct role for cytomegalovirus in coronary arteriopathy of human heart allografts. Circulation 88(4 Part 2): I482, 1993

Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity. Circulation 120(14): 1364-1372, 2009

Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. American Journal of Pathology 147(2): 461-475, 1995

Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. Journal of Heart Transplantation 9(6): 707-711, 1990

Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes. International Journal of Cardiology 111(1): 98, 2006

Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. American Journal of Pathology 147(2): 293-308, 1995

Localization of intra and extracellular lipid in coronary arterial walls from human heart allografts histochemical and ultrastructural evidence. Laboratory Investigation 66(1): 22A, 1992

Cytomegalovirus and coronary artery disease in heart transplant patients--accelerated low density lipoprotein and lipoprotein(a) modification as a proposed factor. Journal of Heart and Lung Transplantation 12(1 Pt 1): 155, 1993

The role of coronary arterial spasm in the progress of coronary heart disease. Zhonghua Nei Ke Za Zhi 20(7): 412-414, 1981

Accelerated coronary artery disease after heart transplantation: The role of enhanced platelet aggregation and thrombosis. Journal of Internal Medicine 233(4): 343-350, 1993

Detection of accelerated coronary artery disease in cardiac allografts by intravascular ultrasound. Journal of the American College of Cardiology 19(3 Suppl. A): 172A, 1992

Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. Journal of Heart and Lung Transplantation 12(5): 724-729, 1993

The detection of the antibodies of human cytomegalovirus in the sera of patients with coronary heart disease. Zhonghua Nei Ke Za Zhi 35(11): 741-743, 1996

Cytomegalovirus and accelerated coronary graft disease an animal model. Journal of Heart & Lung Transplantation 10(1 Part 2): 170, 1991